lobbying_activities: 907544

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
907544	3f5f44a1-9b61-4e99-9387-6e72d6db51ac	Q1	HOLLAND & KNIGHT LLP	18466	SHIRE PHARMACEUTICALS, INC	2010	first_quarter	MMM	Worked to keep provisions regarding biosimilar approval pathway in HR 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Reconciliation Act of 2010; Coverage of Elaprase in state Medicaid Plan.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2010-03-29T14:35:26.860000-04:00